We would like to thank our Lymphoma Canada Scientific Advisory Board for their continued commitment to the lymphoma community. Their collaboration helps to further Lymphoma Canada’s mission of empowering patients and caregivers through education, support, advocacy, and research.
Please view this special letter of thanks
Dr. John Kuruvilla, CHAIR; MD, FRCPC – Princess Margaret Cancer Centre – Toronto, ON
Dr. David MacDonald, MD, FRCPC – The Ottawa Hospital – Ottawa, ON
Dr. Graeme Fraser, MD, FRCPC – Juravinski Cancer Centre – Hamilton, ON
Dr. Tony Reiman, MD, SM, FRCPC – Saint John Regional Hospital – St. John, NB
Dr. Kerry Savage, MD – BC Cancer Agency – Vancouver, BC
Dr. David Hodgson, MD, MPH, FRCPC – Princess Margaret Cancer Centre – Toronto, ON
Dr. Mark Bosch – MD, FRCPC – Saskatchewan Cancer Agency – Regina, SK
Dr. Pamela Skrabek, MD, MSc, FRCPC – CancerCare Manitoba – Winnipeg, MB
Lymphoma Canada could not do what we do without the support of these exceptional professionals from the medical community and would like to thank the following people for their past service to our Scientific Advisory Board:
Dr. Joe Connors, CM, PAST CHAIR; MD Clinical Professor, University of British Columbia; Chair, Lymphoma Tumour Group, British Columbia Cancer Agency
Dr. Isabelle Bence-Bruckler, MD, FRCPC; Hematologist, Associate Professor of Medicine, Member, Blood and Marrow Transplant Program, Ottawa General Hospital
Dr. Spencer Gibson, PhD, Associate Professor, Manitoba Institute of Cell Biology, Department of Biochemistry and Medical Genetic, University of Manitoba
Dr. Mary Gospodarowicz, MD, FRCPC FRCR(Hon) Professor and Chair, Department of Radiation Oncology, University of Toronto, Chief, Radiation Medicine Program, Princess Margaret Hospital
Dr. Kevin Imrie, MD, FRCPC – Physician-in-Chief, Sunnybrook Health Sciences Centre, Vice-Chair, Education, Department of Medicine, University of Toronto, Professor of Medicine, University of Toronto
Dr. Ralph M. Meyer, MD, FRCP(C), Director of the National Cancer Institute of Canada (NCIC) Clinical Trials Group and Holder of the Edith Eisenhauer Chair in Clinical Cancer Research at Queen’s University
Dr. Diponkar Banerjee, MBChB, PhD, FRCPC, Clinical Professor, Department of Laboratory Medicine and Pathology, University of British Columbia; Director, Department of Pathology and Laboratory Medicine, Vancouver Cancer Centre; Provincial Program Leader, Cancer Pathology Program, BC Cancer
Dr. Brent W. Zanke, Vice-President OICR and Director, Ontario Tumour Bank
